We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

China has seen a boost in stem-cell research during the past two years. The country's leaders are spending lavishly on laboratories working on therapeutic cloning as a way to tackle degenerative diseases.

In this feature article Carina Dennis reports that, with this financial support, and in a culture in which there are few moral objections to the use of embryonic stem cells, expatriate Chinese biologists have rushed back home.

But even if China's stem-cell pioneers succeed in developing therapies for degenerative diseases, the cost of such treatment could put the therapies out of the reach of most of the population.

Link to Nature feature article

Reference: Nature 419, 334 (2002)

Related topics